CClinicalTrials.gg
TerminatedNCT00546975Updated Jun 27, 2011

Effect of Oral Nutritional Supplements With Specialized Nutrients on Functional Recovery and Morbidity After Gastrointestinal Surgery

An interventional study of Resource Support® and Resource Protein® in Patients Following Gastrointestinal Surgery, sponsored by Charite University, Berlin, Germany. Terminated at 1 site in Germany. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2011-06-27.

Sponsored by Charite University, Berlin, Germany · Not applicable and Interventional

Why this study was terminated
Compliance unacceptably low.
Phase
Not applicable
Study type
Interventional
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

Nutritional supplementation in postoperative recovery is still debated. Functional impairment is known to develop both secondary to inflammatory processes or secondary to reduced nutritional intake (e.g. disease induced anorexia). Since major surgery represents a traumatic event, surgical patients are at increased risk of malnutrition due to starvation, activation of neuroendocrine stress axis, inflammation and the subsequent increase in metabolic rate. Gastrointestinal surgery in particular can create additional problems as it often directly affects and limits dietary intake postoperatively and these effects frequently continue after discharge. Whereas manifest malnutrition occurs in about 15% of general surgical patients and in about 40% of oncology patients, postoperative weight loss of 5 to 9% occur in all surgical patients during the first two months. Moreover studies have shown that the nutritional status generally declines in hospital and both functional and nutritional status deteriorate for two months after discharge in malnourished surgical patients.

Most studies that have investigated nutritional support in the surgical setting have concentrated on perioperative or short term postoperative supplementation and focussed on in-hospital infection and complication rate.

Hypothesis I:

Nutritional intake is decreased after surgery which results in an impaired nutritional status which in turn is associated with a decreased functional status. Protein rich nutritional supplementation is able to reverse nutritional depletion and restore functionality.

Hypothesis II:

Surgical stress leads to inflammation; inflammation - in addition to reduced nutritional intake - impairs functional status and increases morbidity. Anti-inflammatory, protein rich nutritional supplementation aims to prevent inflammatory complications and therefore improves functional status and reduces morbidity. In patients with high risk for inflammation, a higher effect of anti-inflammatory oral nutrition on recovery of functional status is expected.

This study aims to determine whether 4 week oral nutritional supplementation and/ or specialized nutrients is effective in restoring functional status and reducing morbidity in surgical patients.

02

Conditions studied

  • Patients Following Gastrointestinal Surgery

Keywords

  • gastrointestinal surgery
  • nutritional intervention
  • functional status
  • quality of life
03

In context

Lead sponsor

Charite University, Berlin, Germany is the lead sponsor of 836 studies on the registry; 129 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients who are > 50 years of age and \< 80 years
  2. Patients who have signed a written Informed Consent (Appendix I) prior to admission to the study.
  3. Patients who have an ECOG performance status (presurgery) of 0, 1 or 2 (Appendix II).
  4. Patients able to orally consume 500 mL or more of liquid a day after adaption
  5. Patients undergoing elective gastrointestinal surgery [e.g. Colorectal surgery: colectomy, hemicolectomy, proctectomy; Small bowel resection/surgery; liver resection, splenectomy, non-whipple pancreatic surgery]

Exclusion criteria

Exclusion Criteria:

  1. Patients who are > 80 years of age and \< 50 years
  2. Patients who have co-morbid conditions, uncontrolled metabolic conditions or psychiatric conditions that might make tolerance or evaluation of the feeding formula difficult;
  3. Patients undergoing Whipple´s procedure, gastrectomy, oesophageal resection
  4. Patients who get preoperative nutritional support
  5. Patients taking supplements (EPA, DHA)
  6. Any concomitant severe disease e.g.

    • Patients with respiratory failure (FEV\<0.8l/sec)
    • Patients with renal failure (Cr > 3mg/dl or dialysis patients)
    • Patients with hepatic dysfunction (Child >A)
    • Patients with cardiac failure (NYHA > III)
  7. Patients suffering from an intestinal obstruction or ileus
  8. Patients with an Hb level of >8 g/dL experiencing gastrointestinal haemorrhaging
  9. Patients with HIV
  10. Patients requiring immunosuppression treatments
  11. Pregnancy
  12. Patients undergoing emergency surgery
  13. Other patients determined by a study investigator to be inappropriate for enrolment in this study
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)

Study arms

  • Experimental
    1

    Resource Support® Novartis

    Dietary Supplement: Resource Support®

  • Active comparator
    2

    Resource Protein®, Novartis

    Dietary Supplement: Resource Protein®

  • Placebo comparator
    3

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementResource Support®
  • Dietary supplementResource Protein®
  • Dietary supplementPlacebo
06

What researchers measure

Primary outcomes

  1. Physical Component Summary (from SF 36 Quality of life questionnaire)

    Time frame: 4 weeks

Secondary outcomes

  1. hand grip strength

    Time frame: 4 weeks

07

Study locations

1 site
  • Dept of Surgery CCM
    Berlin, 10117, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00546975
Lead sponsor
Charite University, Berlin, Germany
First posted
Oct 19, 2007
Start date
Oct 2007
Primary completion
Sep 2009
Completion
Sep 2009
Last update
Jun 27, 2011

Study contacts

Herbert Lochs, MD
principal investigator · Charite Universitätsmedizin Berlin Dept. of Gastroenterology

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion